The American Cancer Society’s latest Cancer Statistics report reveals that the U.S. five-year survival rate for all cancers ...

Many of these advances are the result of decades of work and clinical trials. Since the mid-1990s, the American Cancer ...

They plan to run similar trials on seven more patients over the next three years, backed by $4 million from the National ...

Though the findings are positive overall, survival increases since the mid-1990s are especially notable for more fatal ...

Seven in 10 people now survive their cancer five years or more, up from only half in the mid-70s,” said Rebecca Siegel, ...

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

For the first time, the five-year relative survival rate for all cancers combined reached 70%, according to the latest report ...

The five-year relative survival for all cancers combined has reached a milestone, according to the American Cancer Society.

An annual report from the American Cancer Society shows that, for the first time, over 70% of Americans diagnosed with cancer ...

In a Jan. 13th installation of the Stanford Cancer Institute’s “Breakthroughs in Cancer” lecture series, Lawrence Fong ...

Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...

French scientists work on a cancer vaccine, one of several in development that raises hopes of coming breakthroughs - Copyright AFP Abdul MAJEED French scientists ...